Clinical Trial

Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate nerve excitability in participants with cisplatin-induced peripheral neuropathy (cis-PN) using threshold tracking nerve conduction studies (TTNCS). By assessing changes in nerve excitability parameters, the study seeks to enhance understanding of the pathophysiology of cis-PN and identify early markers of neurotoxicity in participants undergoing cisplatin-based chemotherapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-29.
Status change: Not Yet Recruiting → Recruiting 2026-04-18
Trial Details
NCT Number NCT07095998
Lead Sponsor Ka-Wai Ho
Collaborators: Dana-Farber Cancer Institute
Conditions Peripheral Neuropathy Due to Chemotherapy, Peripheral Neuropathy, Neurotoxicity Syndromes, Neuropathy
Enrollment 60 participants
Start Date 2026-01-31
Primary Completion 2027-08-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-22